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lism, is one of famous inflammation markers with a reduction in
Wilson’s disease, whereas serum ferritin is a marker relevant to
iron metabolism. Recently, ferritin is pointed out to be related
with oxidative stress. However, there is still no population
research which showed the relation of CP and ferritin. Therefore,
we investigated the relationship between CP and ferritin including
oxidative stress biomarkers among healthy Japanese (n = 389).
We measured serum CP, ferritin, Fe, highsensitivity Creactive
protein (hsCRP), and urinary oxidative stress biomarkers [H2O2, 8
hydroxy2’deoxyguanosine (8OHdG), 8isoprostane] and so on.
Subjects showed that age; 41.7 ± 10.0 (year), CP; 31.9 ± 6.8 (mg/dl),
ferritin; 123.5 ± 121.0 (ng/ml), hsCRP; 0.89 ± 2.53 (mg/l), 8OHdG;
10.2 ± 4.4 [ng/mg creatinine (Cre)] and H2O2; 6.5 ± 10.9 (µM/g Cre),
(All data mentioned above were expressed as mean ± SD). CP was
significantly and positively correlated with hsCRP and inversely
correlated with ferritin, Fe and 8OHdG. By a multiple logistic
regression analysis, odds ratio of CP according to quartiles of hs
CRP was 4.86, and according to quartiles of 8OHdG was 0.39 after
adjusting for age and other confounding factors. In conclusion,
our findings suggest that CP was an antioxidative biomarker
which controls oxidative stress, whereas ferritin was a marker
which may participate in the generation of oxidative stress.
Key Words: ceruloplasmin, ferritin, 8OHdG, oxidative stress, 
highsensitivity Creactive protein
IntroductionCerul plasmin (CP) is a copper-containing glycoprotein of a
mean molecular weight of 132 kDa that is detected in human
plasma at a concentration of 200 to 400 mg/L. Although its bio-
logical roles are not entirely clear, CP has several characteristics such
as ferroxidase, copper transport, antioxidant, anti-inflammation,
and proinflammatory activity.(1) Ferroxidase activity is associated
with anti-oxidative or anti-inflammatory activity by catalyzing the
oxidation of iron from the Fe2+ ion state to the Fe3+ ion state, a
crucial step for adequate trans-cellular ionic transport.(2) High
levels of CP are associated with atherosclerosis and cardiovascular
disease.(3) Moreover, serum copper levels are risk factor for cardio-
vascular disease.(4,5) Proinflammatory effect of CP is associated
with the formation of hydroxyl radical (•OH) from Fenton-type
reactions of Cu2+ with hydrogen peroxide (H2O2) and the oxidation
of low density lipoprotein. In this reaction, loosely bound copper
in CP is involved.(6,7) The serum levels of CP decreased in Wilson’s
disease, Menkes disease, liver disease, mal-absorption, nutritional
copper deficiency, excessive therapeutic zinc administration and
aceruloplasminemia. On the contrary, CP increased in malignancy,
inflammatory disease, pregnancy, cholestasis, alcoholic liver
injury, and diabetes mellitus.(8,9) However, the characteristics of
CP in healthy population were not clear. Therefore, we considered
that it is quite important to examine the trend of CP in healthy
population from the viewpoint of preventive medicine.
Serum ferritin level represents the amount of stored body iron
and is regarded as one of the oxidative stress markers by providing
Fe2+ to the Fenton reaction. The level of serum iron (Fe2+) is well
known to decrease in chronic inflammatory diseases.(10) Iron is
also involved in oxidative stress by forming •OH from H2O2 and
Fe2+ by the Fenton reaction. Oxidative stress is defined as a situa-
tion in which an increased level of reactive oxygen species (ROS),
such as superoxide anion radical (O2−•) and H2O2, overwhelms the
antioxidative defense capacity, resulting in oxidative damage to
lipids, DNA and proteins.(11) The 8-hydroxy-2'-deoxyguanosine
(8-OHdG) is a product of oxidatively modified DNA base
guanine. Urinary 8-OHdG was considered as a sensitive marker
that relates with diabetes mellitus,(12) chronic renal failure,(13) and
cancer.(14)
We have previously reported that the urinary 8-OHdG was one
of useful prospective biomarkers of lifestyle-related disease
risks.(15) Still, there is no population research which showed the
relation of CP and oxidative stress including high-sensitivity C-
reactive protein (hs-CRP), although the research which examined
the relation between CP and oxidative stress simultaneously in
patients with Behcet’s disease.(16,17) Therefore, the present study
aimed to examine the relationship between CP and oxidative stress
biomarkers (H2O2, 8-OHdG, 8-isoprostane, nitrite/nitrate; NOx)
and ferritin among healthy Japanese.
Materials and Methods
Subjects. A cross-sectional study concerning the relationship
between CP and oxidative stress biomarkers including ferritin
was designed within the framework of a laboratory and field
study. To examine the characteristics of CP in healthy population,
we excluded subjects who had any history of Wilson’s disease,
cancer, stroke, diabetes, ischemic heart disease or asthma, and
who takes any kind of medicines or supplements such as vitamins.
Therefore, we finally used health check-up data of 389 healthy
Japanese individuals whose serum CP levels were able to be
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measured. All subjects were instructed to fast overnight and not
consume any beverage and food except plain water before the
measurement. The ethics committee of Okayama University
approved the study, and all subjects gave informed consent.
Sampling and measurements. Health assessment was per-
formed from September to December, 2007 by collecting blood
samples after overnight fasting for at least 10 h. Serum and plasma
samples were preserved at 4°C for the measurement of red blood
cell (RBC), white blood cell (WBC), hs-CRP, aspartate amino-
transferase (AST), alanine aminotransferase (ALT), γ-glutamyl-
transpeptidase (γ-GTP), triglycerides (TG), high-density lipopro-
tein-cholesterol (HDL-c), low-density lipoprotein-cholesterol
(LDL-c), fasting glucose, fasting insulin, hemoglobin A1c
(HbA1c) of NGSP, uric acid (UA) and creatinine (Cre). So, the
homeostasis model assessment (HOMA-R) levels were calculated
as fasting insulin (μU/ml) × fasting glucose (mg/dl)/405.(18) In
addition, ferritin, Fe3+ and unsaturated iron-binding capacity
(UIBC) were determined in serum samples stored at −80°C until
analyses, because there was a time delay until measuring these
markers.
Anthropometric measurements were performed according to a
standard protocol. Blood pressure (BP) was measured in the
morning after 10 min of rest in the sitting position. Abdominal
circumference was measured horizontally at the umbilical level at
the end of normal expiration by well trained nurses. Body mass
index (BMI) was calculated by body weight (kg)/height (m)2 and
the subjects whose BMI was 25 and over were diagnosed as
obesity according to the criteria for Japanese.(19)
Information on lifestyles including cigarette smoking, alcohol
consumption and exercise was obtained by self-reported question-
naires. The Brinkman index [(number of cigarette per day) ×
(smoking year)] was used to assess smoking status. The amount
of alcohol consumption was calculated by assuming one unit
was equivalent to 9–12 g of ethanol.(20) The habit of alcohol intake
was expressed by drinking frequency and drinking quantity
(number of units) per week. The habit of exercise was shown by
exercise frequency per week.
Analysis of antioxidant and oxidative stress biomarkers.
We used serum CP and urinary H2O2, 8-OHdG, 8-isoprostane, and
plasma NOx. Serum and plasma samples were stored at −80°C
before analysis. Serum CP was analyzed by nephelometry tests.
The tests were able to detect 21–37 (mg/dl) of CP. NOx level was
determined using an ozone-based chemiluminescence assay.(21)
Urinary oxidative stress biomarkers were determined in spot
urine samples stored at −80°C until analysis. Urinary H2O2 was
analyzed by the ferrous ion oxidation xylenol orange version-1
(FOX-1) assay,(22,23) and the intra-assay and inter-assay coeffi-
cients of variation (CV) were 4.3% and 9.7%, respectively.
Measurement of 8-OHdG was carried out with an enzyme-linked
immunosorbent assay (ELISA) kit from the Japan Institute for the
Control of Aging, Fukuroi, Shizuoka, Japan,(24) and the intra-assay
and inter-assay CV were 5.2% and 8.1%, respectively. Møller
and Loft(25) indicated that the correlation coefficient of 8-OHdG
measurements by ELISA between spot and 24-h urine sample was
0.87. Urinary 8-isoprostane was analyzed using commercially
available competitive enzyme immunoassay (EIA) kit (Cayman
Chemical Company, Ann Arbor, MI),(26) and the intra-assay and
inter-assay CV were 5.4% and 11.0%, respectively. Values for
H2O2, 8-OHdG and 8-isoprostane were normalized by per milli-
gram of Cre measured in urine (Cre test kit, R&D Systems,
Minneapolis, MN).
Statistical analysis. The data were expressed as a per-
centage, the arithmetic mean ± SD values. A statistical analysis
was performed using a Mann-Whitney U test or unpaired t test,
two-way analysis of variance (ANOVA) and a multiple logistic
regression analysis. Spearman’s correlation analysis was per-
formed to examine the relation between CP and the other variables
including oxidative stress biomarkers. A multiple logistic regres-
sion analysis was performed to test the relationship between CP
with 8-OHdG, ferritin and hs-CRP, and between ferritin with 8-
OHdG.
A probability value of p<0.05 was considered to be statistically
significant. Data analyses were performed using SPSS software
(SPSS, Chicago, IL; ver. 19.0).
Results
Subject characteristics. The characteristics of the subjects
are summarized in Table 1. The obesity (BMI ≥ 25) person was
20.3% (n = 79). The group of smoker was 39.8% (n = 155), and
the group which drinks alcohol 4 times or more per week was
30.8% (n = 120). In addition, the proportion of no exercise was
59.9% (n = 233). The clinical characteristics by sex are shown in
Table 2. The levels of BMI, abdominal circumference, BP, RBC,
AST, ALT, γ-GTP, LDL-c, TG, UA, Cre, insulin, Fe, ferritin, 8-
isoprostane, and NOx in males were significantly higher than
those in females. On the other hand, the levels of HDL-c, CP, hs-
CRP, UIBC and 8-OHdG in males were significantly lower than
those in females.
Relationship between CP and clinical parameters included
oxidative stress. The results of Spearman’s correlation analysis
between CP and other clinical parameters are presented in Table 3.
In all subjects, CP was significantly and positively correlated with
BMI, WBC, HbA1c and hs-CRP, but it was significantly and
inversely correlated with ferritin, Fe, RBC, Cre, and 8-OHdG. In
addition, ferritin was significantly and positively correlated with
8-OHdG. Only in female subjects, CP was significantly and
positively correlated with AST, ALT, γ-GTP, UA, NOx, and
alcohol consumption.
Table 4 shows the concentration of CP as classified by sex and
age groups. By two-way ANOVA, the concentration of CP in male
subjects was significantly lower than those in female subjects,
although there were no significant differences in the concentration
of CP as classified by age groups.
Multiple logistic regression analysis for CP and ferritin.
Table 5-1 and 5-2 showed the results by multiple logistic
regression analysis about CP or ferritin, according to quartiles of
8-OHdG. The odds ratio of CP according to quartiles of 8-OHdG
was 0.39 in all subjects, and 0.29 in male subjects, and 0.20 in
female subjects, after adjusted for age and other confounding
factors. In addition, p value for trend in all subject, and male or
female subjects after adjusted for age and other confounding
factors were statistically significant. On the other hand, the odds
ratio of ferritin according to quartiles of 8-OHdG was 7.39 in all
subjects, 3.99 in male subjects, and 57.03 in female subjects, after
adjusted for age and other confounding factors. In addition, the
trend analysis showed that the odds ratio of CP concentration
tended to be low with increasing the urinary concentration of 8-
OHdG in all subject, and in male or female subjects after adjusted
for age and other confounding factors.
In addition, Table 6 showed the results by multiple logistic
regression analysis about CP according to quartiles of ferritin. The
odds ratio of CP according to quartiles of ferritin was 0.82 (but
was not statistically significant) in all subjects after adjusted for
age and other confounding factors. And there were no significant
odds ratio after adjusted for age and other related factors in male
and female subjects.
Finally, Table 7 and 8 showed the results by multiple logistic
regression analysis about CP and ferritin according to quartiles of
hs-CRP. The odds ratio of CP according to quartiles of hs-CRP
was 4.86 in all subjects, 4.42 in male subjects, and 14.18 in female
subjects after adjusted for age and other confounding factors. In
addition, the trend analysis showed that there was a significant
and positive association between the odds ratio of CP concentra-
tion and the quartiles of hs-CRP in all subject, and in male or
female subjects after adjusted for age and other confounding
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factors. As to ferritin, the odds ratio in the highest quartile of
hs-CRP was 2.18 in all subjects, 2.27 in male subjects, and 0.80
in female subjects after adjusted for age and other confounding
factors. The p value for trend in all subjects, and male or female
subjects after adjusted for age and other confounding factors were
not statistically significant. However, the p value for trend in all
subject was significant (p = 0.032) when 8-OHdG was excepted
from Model 3 in Table 8 (data not shown).
Table 1. Life style profile
n(%)
All Male Female
Total 389 (100.0) 195 (100.0) 194 (100.0)
Age (year) 20–29 50 (12.9) 25 (12.8) 25 (12.9)
30–39 118 (30.3) 60 (30.8) 58 (29.9)
40–49 133 (34.2) 69 (35.4) 64 (33.0)
50–59 71 (18.3) 33 (16.9) 38 (19.6)
60–69 17 (4.4) 8 (4.1) 9 (4.6)
BMI (kg/m2) <18.5 37 (9.5) 13 (6.7) 24 (12.4)
18.5–24.9 273 (70.2) 135 (69.2) 138 (71.1)
≥25 79 (20.3) 47 (24.1) 32 (16.5)
Lifestyle
Smoking Nonsmoker 234 (60.2) 98 (50.3) 136 (70.1)
Smoker 155 (39.8) 97 (49.7) 58 (29.9)
Alcohol No 123 (31.6) 45 (23.1) 78 (40.2)
3 times or less per week 146 (37.5) 62 (31.8) 84 (43.3)
4 times or more per week 120 (30.8) 88 (45.1) 32 (16.5)
Exercise No 233 (59.9) 94 (48.2) 139 (71.6)
2 times or less per week 107 (27.5) 67 (34.4) 40 (20.6)
3 times or more per week 49 (12.6) 34 (17.4) 15 (7.7)
Table 2. Clinical characteristics of subjects by sex
Each value represents the mean ± SD. Data were analyzed by MannWhitney U test or unpaired t test between male and female.
Clinical parameter All (n = 389) Male (n = 195) Female (n = 194) p value
Age (year) 41.7 ± 10.0 41.7 ± 9.9 41.7 ± 10.2 0.993
BMI (kg/m2) 22.9 ± 3.9 23.6 ± 3.6 22.1 ± 3.9 <0.001
Abdominal circumference (cm) 80.6 ± 10.9 83.9 ± 9.7 77.3 ± 11.0 <0.001
Systolic blood pressure (mmHg) 129.8 ± 21.3 133.9 ± 21.2 125.7 ± 20.7 <0.001
Diastolic blood pressure (mmHg) 77.9 ± 14.4 79.9 ± 14.7 75.8 ± 13.8 0.004
Blood profile
RBC (cell/μl) 468.6 ± 48.0 492.8 ± 48.1 445.2 ± 34.4 <0.001
WBC (cell/μl) 5891.5 ± 1660.6 6036.4 ± 1669.8 5745.9 ± 1642.7 0.065
AST (IU/l) 21.6 ± 9.0 24.0 ± 9.4 19.1 ± 7.8 <0.001
ALT (IU/l) 23.7 ± 19.7 30.1 ± 22.8 17.4 ± 13.2 <0.001
γGTP(IU/l) 36.8 ± 63.0 45.4 ± 36.8 28.2 ± 80.4 <0.001
LDLc (mg/dl) 126.4 ± 35.0 130.2 ± 32.8 122.5 ± 36.8 0.002
HDLc (mg/dl) 62.3 ± 15.1 56.3 ± 13.0 68.3 ± 14.8 <0.001
TG (mg/dl) 105.6 ± 78.6 125.5 ± 95.1 85.5 ± 50.1 <0.001
Uric acid (mg/dl) 5.19 ± 1.40 6.02 ± 1.10 4.36 ± 1.16 <0.001
Creatinine (mg/dl) 0.73 ± 0.15 0.83 ± 0.11 0.62 ± 0.98 <0.001
Insulin (μU/ml) 5.2 ± 3.2 5.6 ± 3.9 4.9 ± 2.4 0.491
Glucose (mg/dl) 93.7 ± 16.0 97.0 ± 20.0 90.4 ± 9.7 <0.001
HbA1c (%) 4.99 ± 0.55 5.04 ± 0.64 4.94 ± 0.42 0.161
HOMAR 1.24 ± 0.89 1.37 ± 1.09 1.11 ± 0.61 0.085
Ceruloplasmin (mg/dl) 31.87 ± 6.79 30.20 ± 5.63 33.54 ± 7.43 <0.001
HsCRP (mg/l) 0.89 ± 2.53 0.87 ± 1.29 0.91 ± 3.35 <0.001
Fe (μg/dl) 113.9 ± 46.6 119.9 ± 37.5 107.7 ± 53.6 0.001
Ferritin (ng/ml) 123.5 ± 121.0 191.7 ± 130.2 54.7 ± 53.8 <0.001
UIBC (μg/dl) 219.6 ± 69.5 206.2 ± 57.9 233.1 ± 77.4 0.001
NOx (μmol/l) 28.07 ± 15.89 29.53 ± 16.21 26.59 ± 15.47 0.017
Urinary profile
H2O2 (μM/g Cre) 6.51 ± 10.85 5.42 ± 6.14 7.61 ± 14.01 0.367
8OHdG (ng/mg Cre) 10.16 ± 4.44 9.35 ± 3.66 10.97 ± 5.00 0.001
8Isoprostane (pg/mg Cre) 781.8 ± 613.1 875.6 ± 603.0 687.5 ± 610.2 <0.001
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Discussion
Inverse association of CP with ferritin was observed in healthy
population of this study, although CP and ferritin were positively
associated with hs-CRP, a biomarker of inflammatin. The same
relationship between CP, ferritin and hs-CRP was also observed
in amyotrophic lateral sclerosis (ALS) patients.(27) In ALS,
increased levels of serum ferritin may contribute to the etiology.
Lower levels of CP might contribute to the pathogenesis of
alzhaimer’s disease although an inverse relation between CP and
ferritin was observed not only in alzheimer’s disease but also in
healthy population.(28) However, these previously reports were
based on the result by univariate analysis. The inverse association
of CP with ferritin in the present study was robust in healthy
population by multivariate statistics. Moreover, this study demon-
strated that CP was inversely associated with urinary 8-OHdG, a
biomarker of oxidative stress, and then ferritin was positively
associated with 8-OHdG. Therefore, it is speculated that CP may
act antioxidatively against oxidative stress induced by ferritin.
Ferritin is an iron binding protein that can store Fe3+ ions and
Table 3. Spearman’s correlation of ceruloplasmin with each parameter
Variable All (n = 389) Male (n = 195) Female (n = 194)
r p r p r p
Age (year) 0.049 0.334 0.007 0.925 0.088 0.221
BMI (kg/m2) 0.107 0.034 0.049 0.492 0.279 <0.001
Abdominal circumference (cm) 0.081 0.109 0.048 0.503 0.254 <0.001
Systolic blood pressure (mmHg) 0.008 0.868 0.008 0.914 0.104 0.148
Diastolic blood pressure (mmHg) 0.075 0.140 0.023 0.751 0.184 0.010
Blood profile
RBC (cell/μl) –0.109 0.037 0.002 0.979 0.036 0.627
WBC (cell/μl) 0.134 0.008 0.146 0.042 0.184 0.010
AST (IU/l) 0.001 0.979 –0.016 0.824 0.198 0.006
ALT (IU/l) –0.024 0.644 –0.047 0.511 0.204 0.004
γGTP (IU/l) 0.003 0.950 0.070 0.332 0.196 0.006
LDLc (mg/dl) 0.056 0.274 0.090 0.210 0.105 0.145
HDLc (mg/dl) 0.055 0.279 –0.035 0.626 –0.035 0.630
TG (mg/dl) 0.059 0.243 0.141 0.050 0.120 0.097
Glucose (mg/dl) 0.060 0.240 0.130 0.071 0.117 0.103
Insulin (μU/ml) 0.067 0.189 0.067 0.353 0.081 0.259
HbA1c (%) 0.115 0.024 0.144 0.045 0.130 0.070
HOMAR 0.068 0.178 0.079 0.273 0.101 0.161
Uric acid (mg/dl) –0.049 0.333 0.056 0.438 0.175 0.015
Creatinine (mg/dl) –0.227 <0.001 –0.108 0.131 −0.086 0.234
Inflammation markers
HsCRP (mg/l) 0.245 <0.001 0.213 0.003 0.361 <0.001
Fe (μg/dl) –0.130 0.010 –0.169 0.018 –0.028 0.701
Ferritin (ng/ml) –0.182 <0.001 –0.160 0.026 0.062 0.391
UIBC (μg/dl) 0.204 <0.001 0.216 0.002 0.129 0.074
Oxidative stress markers
H2O2 (μm/g Cre) 0.012 0.819 0.020 0.784 0.006 0.932
8OHdG (ng/mg Cre) –0.118 0.020 –0.224 0.002 –0.113 0.116
8Isoprostane (pg/mg Cre) –0.003 0.948 0.111 0.122 –0.011 0.883
NOx (μmol/l) 0.034 0.503 –0.022 0.761 0.145 0.044
Lifestyle
Smoking value 0.040 0.426 0.092 0.199 0.102 0.158
Alcohol consumption 0.040 0.428 0.077 0.287 0.148 0.039
Exercise –0.086 0.089 –0.017 0.815 –0.045 0.533
Table 4. Effect of sex and age on ceruloplasmin
Each value represents the mean ± SD. Data were analyzed by twoway ANOVA (sex and age as main effects).
Groups
Age
Twoway ANOVA20–29 30–39 40–49 50–59 60–69
All (n = 389) (n = 50) (n = 118) (n = 133) (n = 71) (n = 17)
Male (n = 195) (n = 25) (n = 60) (n = 69) (n = 33) (n = 8) Main effects Interaction 
(S × A)Female (n = 194) (n = 25) (n = 58) (n = 64) (n = 38) (n = 9) Sex (S) Age (A)
p<0.001 p = 0.486 p = 0.348
All 31.87 ± 6.79 30.69 ± 6.57 31.91 ± 6.02 32.18 ± 6.45 31.57 ± 8.22 33.78 ± 8.53
Male 30.20 ± 5.63 29.16 ± 4.44 30.36 ± 5.03 31.16 ± 5.65 28.82 ± 6.12 29.66 ± 9.72
Female 33.54 ± 7.43 32.22 ± 7.97 33.51 ± 6.57 33.27 ± 7.10 33.96 ± 9.09 37.44 ± 5.55
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is distributed in the whole body. Serum levels of ferritin are
considered to reflect body iron store.(29) Although two opposite
functions such as an antioxidative function by its chelating effect
of free iron(30) and a promotor function for oxidative stress by
releasing free iron(31) were reported, there are many epidemio-
logical evidences to show a positive association of ferritin with
urinary 8-OHdG.(32–34) This study showed a positive association of
ferritin with urinary 8-OHdG, indicating its promotion of oxida-
tive stress.
CP is known as an acute phase protein which increases 2- or 3-
fold in inflammatory conditions. However, it has contradictory
functions between pro-inflammation and anti-oxidation. The
Table 51. Odds ratio of ceruloplasmin according to quartiles of 8OHdG
Data were analyzed by multiple logistic regression analysis. Data in pareutheses were 95% CI. Model 1: Not adjusted. Model 2:
Adjusted for sex and age. Model 3: Adjusted for age, sex, BMI, Systolic blood pressure, RBC, WBC, ALT, LDLc, HOMAR, HbA1c,
HsCRP, NOx, ferritin, UA, Cre, Smoking, Alcohol and Exercise. Model 4: Adjusted for age, BMI, Systolic blood pressure, RBC, WBC,
ALT, LDLc, HOMAR, HbA1c, HsCRP, NOx, ferritin, UA, Cre, Smoking, Alcohol and Exercise.
Quartiles of 8OHdG
p for trend
Q1 Q2 Q3 Q4
All (n = 389)
Model 1 1.00 0.73 (0.41–1.32) 0.70 (0.39–1.26) 0.55 (0.31–0.98) 0.047
Model 2 1.00 0.75 (0.41–1.36) 0.58 (0.31–1.07) 0.41 (0.22–0.76) 0.004
Model 3 1.00 0.78 (0.41–1.50) 0.62 (0.32–1.19) 0.39 (0.19–0.80) 0.009
Male (n = 195)
Model 1 1.00 0.67 (0.29–1.57) 0.41 (0.17–0.97) 0.31 (0.13–0.73) 0.004
Model 4 1.00 0.71 (0.28–1.77) 0.39 (0.15–1.02) 0.29 (0.11–0.78) 0.007
Female (n = 194)
Model 1 1.00 0.81 (0.36–1.84) 0.74 (0.33–1.68) 0.53 (0.23–1.19) 0.128
Model 4 1.00 0.69 (0.26–1.86) 0.56 (0.21–1.49) 0.20 (0.63–0.65) 0.008
Table 52. Odds ratio of ferritin according to quartiles of 8OHdG
Data were analyzed by multiple logistic regression analysis. Data in pareutheses were 95% CI. Model 1: Not adjusted. Model 2:
Adjusted for sex and age. Model 3: Adjusted for sex, age, BMI, Systolic blood pressure, RBC, WBC, ALT, LDLc, HOMAR, HbA1c,
HsCRP, NOx, CP, UA, Cre, Smoking, Alcohol and Exercise. Model 4: Adjusted for age, BMI, Systolic blood pressure, RBC, WBC, ALT,
LDLc, HOMAR, HbA1c, HsCRP, NOx, CP, UA, Cre, Smoking, Alcohol and Exercise.
Quartiles of 8OHdG
p for trend
Q1 Q2 Q3 Q4
All (n = 389)
Model 1 1.00 1.78 (0.99–3.20) 0.95 (0.53–1.71) 1.48 (0.83–2.63) 0.560
Model 2 1.00 2.03 (0.85–4.82) 1.84 (0.75–4.53) 5.76 (2.24–14.8) 0.001
Model 3 1.00 2.59 (0.96–7.01) 2.37 (0.84–6.67) 7.39 (2.39–22.9) 0.001
Male (n = 195)
Model 1 1.00 2.49 (1.06–5.82) 1.54 (0.66–3.63) 2.49 (1.06–5.82) 0.099
Model 4 1.00 3.10 (1.18–8.16) 1.73 (0.62–4.80) 3.99 (1.36–11.71) 0.040
Female (n = 194)
Model 1 1.00 8.99 (3.01–26.9) 11.77 (3.92–35.32) 36.31 (11.19–117.83) <0.001
Model 4 1.00 18.73 (4.79–73.28) 17.16 (4.43–66.44) 57.03 (12.86–252.96) <0.001
Table 6. Odds ratio of ceruloplasmin according to quartiles of ferritin
Data were analyzed by multiple logistic regression analysis. Data in pareutheses were 95% CI. Model 1: Not adjusted. Model 2:
Adjusted for sex and age. Model 3: Adjusted for age,sex, BMI, Systolic blood pressure, RBC, WBC, ALT, LDLc, HOMAR, HbA1c,
8OHdG, NOx, HsCRP, UA, Cre, Smoking, Alcohol and Exercise. Model 4: Adjusted for age, BMI, Systolic blood pressure, RBC, WBC,
ALT, LDLc, HOMAR, HbA1c, 8OHdG, NOx, HsCRP, UA, Cre, Smoking, Alcohol and Exercise.
Quartiles of Ferritine
p for trend
Q1 Q2 Q3 Q4
All (n = 389)
Model 1 1.00 0.93 (0.52–1.66) 0.74 (0.42–1.32) 0.50 (0.28–0.89) 0.014
Model 2 1.00 1.01 (0.56–1.84) 1.18 (0.57–2.45) 0.83 (0.38–1.82) 0.756
Model 3 1.00 1.16 (0.58–2.31) 1.34 (0.57–3.19) 0.82 (0.32–2.12) 0.788
Male (n = 195)
Model 1 1.00 0.55 (0.24–1.28) 0.50 (0.22–1.17) 0.46 (0.20–1.07) 0.076
Model 4 1.00 0.57 (0.23–1.43) 0.53 (0.21–1.36) 0.49 (0.18–133) 0.169
Female (n = 194)
Model 1 1.00 1.10 (0.49–2.46) 1.14 (0.50–2.60) 1.42 (0.62–3.22) 0.412
Model 4 1.00 1.25 (0.47–3.31) 1.02 (0.36–2.91) 1.55 (0.48–4.98) 0.562
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increase in CP was considered to be a risk factor for cardio-
vascular disease,(35) which is associated with copper ion-related
oxidative stress and augmented oxidative stress by nitric oxide
consumption of CP. However, according to the relationship
between diabetes mellitus and CP, the changes for CP were
inconsistent.(36–38) In this inconsistency, opposite functions such as
copper ion related oxidative stress and antioxidative function
related to ferroxidase are involved in the pathophysiology of
diabetes mellitus. In this study, CP was inversely associated with
urinary 8-OHdG in all subjects and as well in male subjects. On
the other hand, the level of plasma NOx in only female subjects
was significantly and positively correlated with serum CP.
However, urinary 8-isoprostane and H2O2 were not significantly
correlated with serum CP. Moreover, the level of NOx was
significantly and positively correlated with hs-CRP in all subjects
(data not shown). Although the concentration of hs-CRP was not
high enough, the subjects with the high level of hs-CRP also
showed higher level of NOx and CP among the healthy subjects
in our study. So, serum CP may prevent the oxidative stress and
reduce the levels of Fe2+ and 8-OHdG among the healthy subjects.
In healthy population study, the result of this study is first
evidence to show antioxidative function of CP in association
with ferritin.
Several limitations of the study should be noted. First, causal
relationships could not be determined because this study was a
cross-sectional study. Second, some reporting bias may have
been introduced because the information on lifestyle habits like
smoking and drinking was obtained via self-reported question-
naires. Third, sample size of this research was not large enough,
and also we evaluated only in healthy subjects. Therefore, clear
relationships between CP and parameters may not be noted in this
study. Further studies with large sample size including patients
with the high level CP and/or hs-CRP and longitudinal examina-
tion are required to confirm the antioxidative function of the serum
CP.
In conclusion, our findings suggest that CP was an antioxidative
biomarker controls oxidative stress, whereas ferritin was a marker
which may participate in the generation of oxidative stress.
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Table 7. Odds ratio of ceruloplasmin according to quartiles of hsCRP
Data were analyzed by multiple logistic regression analysis. Data in pareutheses were 95% CI. Model 1: Not adjusted. Model 2:
Adjusted for sex and age. Model 3: Adjusted for age, sex, BMI, Systolic blood pressure, RBC, WBC, ALT, LDLc, HOMAR, HbA1c,
8OHdG, NOx, ferritin, UA, Cre, Smoking, Alcohol and Exercise. Model 4: Adjusted for age, BMI, Systolic blood pressure, RBC, WBC,
ALT, LDLc, HOMAR, HbA1c, 8OHdG, NOx, ferritin, UA, Cre, Smoking, Alcohol and Exercise.
Quartiles of hsCRP
p for trend
Q1 Q2 Q3 Q4
All (n = 389)
Model 1 1.00 1.46 (0.81–2.66) 1.56 (0.87–2.78) 3.99 (2.17–7.32) <0.001
Model 2 1.00 1.67 (0.90–3.10) 1.91 (1.04–3.53) 5.39 (2.81–10.34) <0.001
Model 3 1.00 1.55 (0.80–3.00) 2.02 (1.01–4.04) 4.86 (2.16–10.92) <0.001
Male (n = 195)
Model 1 1.00 1.23 (0.53–2.87) 1.06 (0.46–2.42) 3.11 (1.32–7.33) 0.018
Model 4 1.00 0.99 (0.38–2.59) 1.28 (0.45–3.63) 4.42 (1.38–14.14) 0.014
Female (n = 194)
Model 1 1.00 1.34 (0.56–3.23) 3.68 (1.57–8.63) 7.08 (2.87–17.49) <0.001
Model 4 1.00 1.48 (0.54–4.09) 6.53 (2.16–19.76) 14.18 (3.91–51.41) <0.001
Table 8. Odds ratio of ferritin according to quartiles of HsCRP
Data were analyzed by multiple logistic regression analysis. Data in pareutheses were 95% CI. Model 1: Not adjusted. Model 2:
Adjusted for sex and age. Model 3: Adjusted for sex, age, BMI, Systolic blood pressure, RBC, WBC, ALT, LDLc, HOMAR, HbA1c,
8OHdG, NOx, CP, UA, Cre, Smoking, Alcohol and Exercise. Model 4: Adjusted for age, BMI, Systolic blood pressure, RBC, WBC, ALT,
LDLc, HOMAR, HbA1c, 8OHdG, NOx, CP, UA, Cre, Smoking, Alcohol and Exercise.
Quartiles of HsCRP
p for trend
Q1 Q2 Q3 Q4
All (n = 389)
Model 1 1.00 1.39 (0.76–2.53) 2.86 (1.59–5.15) 3.41 (1.87–6.21) <0.001
Model 2 1.00 0.88 (0.38–2.04) 2.10 (0.93–4.75) 2.72 (1.18–6.28) 0.004
Model 3 1.00 0.83 (0.32–2.21) 2.41 (0.91–6.42) 2.18 (0.67–7.08) 0.076
Male (n = 195)
Model 1 1.00 1.12 (0.47–2.62) 3.01 (1.29–7.00) 3.09 (1.32–7.27) 0.001
Model 4 1.00 1.06 (0.38–2.94) 3.59 (1.21–10.65) 2.27 (0.67–7.72) 0.066
Female (n = 194)
Model 1 1.00 3.15 (1.34–7.43) 3.34 (1.44–7.75) 2.47 (1.07–5.72) 0.040
Model 4 1.00 2.28 (0.76–6.83) 0.92 (0.28–2.97) 0.80 (0.21–3.05) 0.477
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BMI body mass index
BP blood pressure
CP ceruloplasmin
Cre creatinine
CV coefficients of variation
EIA enzyme immunoassay
ELISA enzyme-linked immunosorbent assay
FOX-1 ferrous ion oxidation xylenol orange version-1
γ-GTP γ-glutamyltranspeptidase
HbA1c hemoglobin A1c
HDL-c high-density lipoprotein-cholesterol
H2O2 hydrogen peroxide
HOMA-R homeostasis model assessment
hs-CRP high-sensitivity C-reactive protein
LDL-c low-density lipoprotein-cholesterol
NOx nitrite/nitrate
O2−• superoxide anion radical
•OH hydroxyl radical
8-OHdG 8-hydroxy-2'-deoxyguanosine
RBC red blood cell
ROS reactive oxygen species
TG triglycerides
UA uric acid
UIBC unsaturated iron-binding capacity
WBC white blood cell
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